Steris Analyst Price Targets - Benzinga

Steris PLC

STENYSE

Trade with Public

Trade with Public

$225.18

N/A

마지막 업데이트: Oct 20, 4:00 PM

$225.18

N/A

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Steris Analyst Price Targets - Benzinga

Steris Analyst Price Targets

Wall Street analyst price targets and consensus rating for Steris (STE).

Price Target Range — 10 Quarters

Analyst Consensus — 8 Analysts

1S.Buy

5Buy

2Hold

Consensus RatingOverweight# Analysts8Avg. Consensus PT$267Upside to Avg. PT+18.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	UBS	Patrick Wood	PT Cut	Buy	$275→$270
Aug 7, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$270→$275
Jul 28, 2026	UBS	Patrick Wood	Initiate	Buy	$275
May 13, 2026	Keybanc	Brett Fishbin	PT Cut	Overweight	$291→$269
Aug 8, 2025	Morgan Stanley	Patrick Wood	PT Raise	Overweight	$276→$295
Jul 22, 2025	Keybanc	Brett Fishbin	PT Raise	Overweight	$277→$288
Jul 15, 2025	Morgan Stanley	Patrick Wood	Upgrade	Equal-Weight→Overweight	$260→$276
May 29, 2025	Jefferies	David Windley	Initiate	Hold	$263
May 19, 2025	Morgan Stanley	Patrick Wood	PT Raise	Equal-Weight	$240→$260
May 16, 2025	JMP Securities	David Turkaly	PT Raise	Market Outperform	$265→$280
May 15, 2025	Stephens & Co.	Steven Etoch	Maintained	Overweight	$250
May 12, 2025	Morgan Stanley	Patrick Wood	PT Raise	Equal-Weight	$230→$240
Apr 10, 2025	JMP Securities	David Turkaly	Maintained	Market Outperform	$265
Apr 7, 2025	Needham	Mike Matson	Maintained	Hold	—
Feb 6, 2025	JMP Securities	Reni Benjamin	Maintained	Market Outperform	$265
Feb 6, 2025	Stephens & Co.	Jacob Johnson	Maintained	Overweight	$240
Feb 3, 2025	Piper Sandler	Jason Bednar	PT Raise	Overweight	$260→$265
Nov 18, 2024	JMP Securities	David Turkaly	Maintained	Market Outperform	$265
Nov 8, 2024	Needham	Mike Matson	Maintained	Hold	—
Nov 7, 2024	Stephens & Co.	Jacob Johnson	Maintained	Overweight	$260

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Buy on Steris, Lowers Price Target to $270

UBS analyst Patrick Wood maintains Steris (NYSE:STE) with a Buy and lowers the price target from $275 to $270.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On Steris with Buy Rating, Announces Price Target of $275

UBS analyst Patrick Wood initiates coverage on Steris (NYSE:STE) with a Buy rating and announces Price Target of $275.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on Steris, Lowers Price Target to $269

Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and lowers the price target from $291 to $269.

Benzinga Newsdesk

Sotera Health Trades At Deep Discount Despite Best-In-Class Margins: Analyst

Sotera Health, a sterilization solutions provider, is gaining investor attention due to easing litigation and improving cash flow.

Vandana Singh

PRO
Keybanc Maintains Overweight on Steris, Raises Price Target to $288

Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $277 to $288.

Benzinga Newsdesk